3月24日 - ** 消费者健康公司Kenvue（KVUE.N）股价上涨1.20%，至23.60美元（盘前
** 彭博新闻社周日报导称，TOMS Capital Investment Management已入股KVUE，并推动其进行变革 (link)
** 报导称，这家总部位于纽约的对冲基金正在敦促KVUE考虑全部出售或剥离部分资产
** 报告补充道，目前尚无法立即得知TOMS的持股规模
** 本月初，KVUE与激进股东Starboard就代理权之争达成 (link) 和解，并任命了三名董事
** 截至上次收盘，年初至今股价上涨约9
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.